https://charts.traderzeitung.de/phases/US30068X1037 string(1479) "{"isin":"US30068X1037","name":"Exagen Inc","stock_id_xnas":10024221,"stock_id_xnys":null,"generated_at":"2026-08-09 08:00:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.5,"close_at":"2026-08-05 15:28:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.62,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":1.8462},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":6.65,"close_at":"2026-08-05 22:49:00","complete":true,"perf_pct":0.4532}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.69,"close_at":"2026-08-06 15:27:00","complete":true,"perf_pct":0.6015},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.63,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":-0.8969},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":6.6,"close_at":"2026-08-06 22:56:00","complete":true,"perf_pct":-0.4525}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":6.66,"close_at":"2026-08-07 15:28:00","complete":true,"perf_pct":0.9091},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":6.89,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":3.4535},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

Exagen Aktie News & Nachrichten

[WKN: A2PRXT | Symbol: XGN]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Exagen gefunden werden.

Exagen Nachrichtenticker öffnen

MT Newswires 05.08.2026 14:37 Uhr

B. Riley passt Kursziel für Exagen von 8 $ auf 12 $ an, belässt die Einstufung auf Kaufen

08:36 EDT, 05.08.2026 (MT Newswires) -- Exagen (XGN) hat laut von FactSet befragten Analysten ein durchschnittliches Rating von Kaufen und ein mittler

MT Newswires 25.06.2026 13:25 Uhr

Roth Capital nimmt die Coverage für Exagen mit einem 'Kaufen'-Rating und einem Kursziel von 8 $ auf

07:24 AM EDT, 06/25/2026 (MT Newswires) -- Exagen (XGN) hat laut von FactSet befragten Analysten ein durchschnittliches "Kaufen"-Rating und ein mittle